Gilead Sciences (GILD) Fails to deliver data

Key failure to deliver metrics for Gilead Sciences:

• Last SEC data release: 2026-06-30
• Last 15 days FTD volume: A$0 M
• Last 3 months FTD volume: A$9.72 M
• Last 12 months FTD volume: A$0.11 B

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Gilead Sciences (GILD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Gilead Sciences (GILD) - since 2013

Gilead Sciences (GILD) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Johnson & Johnson JNJ	A$0.12 B	A$0.27 B	🇺🇸 USA
Pfizer PFE	A$0.24 B	A$0.33 B	🇺🇸 USA
AbbVie ABBV	A$45.01 M	A$0.27 B	🇺🇸 USA
Eli Lilly LLY	A$92.37 M	A$0.46 B	🇺🇸 USA
Amgen AMGN	A$27 M	A$0.42 B	🇺🇸 USA
Biogen BIIB	A$5.69 M	A$53.5 M	🇺🇸 USA
Illumina ILMN	A$45.98 M	A$69.75 M	🇺🇸 USA
Vertex Pharmaceuticals VRTX	A$24.07 M	A$0.12 B	🇺🇸 USA
Merck MRK	A$16.06 M	A$0.20 B	🇺🇸 USA